The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial.
about
Treatment of fever after stroke: conflicting evidenceShould we treat pyrexia? And how do we do it?Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspectiveThe Effect of Paracetamol on Core Body Temperature in Acute Traumatic Brain Injury: A Randomised, Controlled Clinical TrialThe effect of covariate adjustment for baseline severity in acute stroke clinical trials with responder analysis outcomes.Application of mild therapeutic hypothermia on stroke: a systematic review and meta-analysisAn early rise in body temperature is related to unfavorable outcome after stroke: data from the PAIS studyTargeted temperature management in the ICU: guidelines from a French expert panel.Modern medical management of acute ischemic stroke.Neuroprotection or increased brain damage mediated by temperature in stroke is time dependent.Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials?Temporal profile of body temperature in acute ischemic stroke: relation to stroke severity and outcome.Hypothermia protects human neurons.Use of paracetamol in ischaemic stroke patients: evidence from VISTA.Pharmacotherapy of fever control among hospitalized adult patients.Early temperature and mortality in critically ill patients with acute neurological diseases: trauma and stroke differ from infection.The added value of ordinal analysis in clinical trials: an example in traumatic brain injury.New considerations in the design of clinical trials for traumatic brain injuryBrain injury clinical trials: new agents or new statistics?TRPA1 mediates the hypothermic action of acetaminophen.Low body temperature associated with severe ischemic stroke within 6 hours of onset: The Bergen NORSTROKE Study.Temporal profile of body temperature in acute ischemic stroke: relation to infarct size and outcome.Confusion: acetaminophen dosing changes based on NO evidence in adults.Can paracetamol (acetaminophen) be administered to patients with liver impairment?Pharmacokinetic properties of intramuscular versus oral syrup paracetamol in Plasmodium falciparum malaria.Effect of Treatment Delay, Stroke Type, and Thrombolysis on the Effect of Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome after Acute Stroke: A Systematic Review and Meta-Analysis of Individual Patient from Randomised Trials.Persistent middle cerebral artery occlusion associated with lower body temperature on admission.Advancing care for traumatic brain injury: findings from the IMPACT studies and perspectives on future research.Update on the Preventive Antibiotics in Stroke Study (PASS): a randomised controlled phase 3 clinical trial.Intracerebral hemorrhage specific intensity of care quality metrics.Hypothermia for Stroke: call to action 2010.Temperature management in stroke - an unsolved, but important topic.Strategies to improve recovery in acute ischemic stroke patients: Iberoamerican Stroke Group Consensus.Hyperacute management of ischemic stroke.The intensive care management of acute ischemic stroke: an overview.Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke.Effect of Acetaminophen Ingestion on Thermoregulation of Normothermic, Non-febrile Humans.European Stroke Organisation (ESO) guidelines for the management of temperature in patients with acute ischemic stroke.Normothermia and Stroke.The FDA Acetaminophen Advisory Committee Meeting - what is the future of acetaminophen in the United States? The perspective of a committee member.
P2860
Q27016022-F81DE5DD-A065-41F6-9D0C-EBB7685879A6Q28066775-DA055409-1E4A-4A80-A92B-7AB425E09FD8Q28393202-7C81EFD8-2C6B-405E-A1A1-19B985F05D19Q28551575-C5FE36F5-6CE4-4D60-B791-2D5D5D798537Q30416378-B93D10E2-81C6-45FB-BE81-FADD8D18DFE3Q30513494-D8ACA8DD-FBC3-4E82-B788-39984B6740DFQ33705526-ED5C214E-E946-4EA3-A7D8-A22D2FA7815BQ33812414-C1AED398-5D57-41CB-A881-758BCB7DEC8BQ33981085-E880B9FD-073A-49EE-88C0-58AC47311689Q34170175-BBFA8D51-B664-4323-987A-D1481A332516Q34171143-1884B70E-65FB-43C2-BB9A-D466BBF5A382Q34449642-93D38350-4606-4B69-BBD3-C7929A0A7A65Q34531612-6E2AB0F6-5B1D-4FBD-9188-F1ECB79BD8CBQ34587392-77BFCD19-432D-4B1A-9E0F-F6EDA1C7D308Q34621396-AE1C26D6-290E-4ADB-BF68-6254DE7DCF36Q35554858-7F8798BE-11DF-48FB-993A-C89F7FE0B35EQ35558241-1D14B1F8-1D4A-4E54-8279-C82B7F6E4EA6Q35889519-4BEF7CE2-06AC-452C-BD71-3EA0A8DDE7D5Q35908024-92620047-106E-479B-A4E6-D3D9075A4203Q35942820-E0CC98A2-C215-4963-A492-2352309D2128Q36027236-172011BB-BF25-4EE0-B92D-45B8F3F24F47Q36200157-28BB10F4-53C5-4B4C-AE4F-46CFDFC26842Q36648985-CC9399FB-9AA5-41CB-9647-ED02A07B3B87Q36802077-58E7C8A1-C6D6-453E-B20D-5F63DE41301AQ36842213-DE453443-6C77-4604-84CB-D8733C7C5728Q36854734-B1A934A0-60CC-4A4C-96CB-8DBCD3E3B7A7Q36944531-3FD87EB1-975D-4ABC-B9C8-B8188C62ED48Q37493013-58B56565-6B04-406A-A317-36F4A1DBF8F2Q37724069-A3E6F493-3ED8-4D6B-B680-D2B635EA30A6Q37809772-5E6AA324-EA2F-4C5A-9EB6-8C504835136FQ37810557-526ABE45-9F8C-4302-82F6-B3B2E20FBFDEQ37864498-42243E55-A9F6-4723-BADB-261B5A0B8B85Q38117170-23CEFBA1-EEBE-42F0-BAA5-A464863902F7Q38185952-97157BBD-7145-4943-B137-5EF3347D7BC9Q38198543-4C9A2EE1-DE4E-44BB-B84D-5F998BF41E46Q38366399-9E4C8061-12CF-41DC-B1AE-9C43AE413275Q38961118-C3FAD2DD-7CFE-4A06-95D7-4E2C4547FA69Q38987914-CD5660CF-06FA-4660-938A-14616A5C5B56Q39154051-167A3486-8836-496F-B521-515D49205EDFQ39298910-9C7F394A-E439-496D-86B7-38B80ACB2DF2
P2860
The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The Paracetamol (Acetaminophen ...... o-controlled, phase III trial.
@en
type
label
The Paracetamol (Acetaminophen ...... o-controlled, phase III trial.
@en
prefLabel
The Paracetamol (Acetaminophen ...... o-controlled, phase III trial.
@en
P2093
P921
P1433
P1476
The Paracetamol (Acetaminophen ...... o-controlled, phase III trial.
@en
P2093
Diederik W J Dippel
H Bart van der Worp
H Maarten A van Gemert
Heleen M den Hertog
Jan van Gijn
L Jaap Kappelle
PAIS Investigators
Peter J Koudstaal
P304
P356
10.1016/S1474-4422(09)70051-1
P577
2009-03-16T00:00:00Z